Ew N. Levarht
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.
Journal: Rheumatology (Oxford, England)
Published: February 23, 2026
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: February 23, 2026
Topoisomerase 1-DNA complexes are preferentially recognised by a subset of anti-topoisomerase 1 autoantibodies and their corresponding B cell receptors in systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: May 01, 2025
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 12, 2024
Anti-carbamylated protein antibodies in systemic sclerosis.
Journal: Arthritis research & therapy
Published: February 25, 2023
Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls.
Journal: Clinical and experimental rheumatology
Published: October 15, 2019
Complement component C1q is produced by isolated articular chondrocytes.
Journal: Osteoarthritis and cartilage
Published: April 09, 2019
Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies.
Journal: European journal of gastroenterology & hepatology
Published: December 08, 2016
Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation.
Journal: Annals of the rheumatic diseases
Published: January 22, 2016
The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.
Journal: Arthritis research & therapy
Published: August 21, 2015
Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent.
Journal: Rheumatology (Oxford, England)
Published: July 17, 2015
Last Updated: 09/26/2026